Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

NCT04489459 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae

Interventions

DRUG: Colistin
DRUG: Meropenem
DRUG: Tigecycline

Sponsor

Al-Azhar University